← Product Code [MRV](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/MRV) · K120247

# EASYDEX (K120247)

_Vineland Syrup, Inc. · MRV · Jun 21, 2012 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/MRV/K120247

## Device Facts

- **Applicant:** Vineland Syrup, Inc.
- **Product Code:** [MRV](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/MRV.md)
- **Decision Date:** Jun 21, 2012
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.1345
- **Device Class:** Class 2
- **Review Panel:** Clinical Chemistry

## Indications for Use

EasyDex is a flavored non-carbonated beverage containing specific quantities of dextrose (D-glucose). The manufactured beverages contain three (3) different quantities of glucose; 50, 75, and 100 grams quantities per 10 oz. bottle. This product is used in the administration of an in Vitro Diagnostic Glucose Tolerance Test in the evaluation of diabetes mellitus and other related disease conditions. This product is for oral consumption only.

## Device Story

EasyDeX is a flavored, non-carbonated, water-based beverage containing precise quantities of dextrose (50g, 75g, or 100g). Used as an accessory for oral glucose tolerance tests (OGTT) to evaluate diabetes mellitus and related conditions. Administered orally to patients in a clinical setting following an overnight fast. The beverage provides a standardized glucose load, after which blood samples are drawn at specific intervals to measure glucose levels. These measurements allow clinicians to assess insulin secretion and action. The device is a consumable product; no electronic or mechanical operation is involved.

## Clinical Evidence

No clinical data provided. Bench testing included stability studies evaluating sugar composition and microbiological (yeast and molds) testing over the shelf life. Stability protocols and acceptance criteria were reviewed and found acceptable.

## Technological Characteristics

Water-based flavored beverage containing dextrose. Concentrations: 50g, 75g, 100g per 10 oz bottle. Non-carbonated. Packaging: Plastic bottle with tamper-evident band. Shelf life: 18 months.

## Regulatory Identification

A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

## Special Controls

*Classification.* Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

## Predicate Devices

- Glucose Tolerance Beverage (k032753)

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

1

# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number:
k120247

B. Purpose for Submission:
New accessory to a glucose device

C. Measurand:
D-glucose values

D. Type of Test:
Glucose tolerance beverage

E. Applicant:
Vineland Syrup, Inc.

F. Proprietary and Established Names:
EasyDeX

G. Regulatory Information:
1. Regulation section:
21 CFR § 862.1345; Glucose test system
2. Classification:
Class II
3. Product code:
MRV; Drink, Glucose Tolerance
4. Panel:
Clinical Chemistry (75)

H. Intended Use:
1. Intended use(s):
See Indications for use below.
2. Indication(s) for use:
EasyDex is a flavored non-carbonated beverage containing specific quantities of dextrose (D-glucose). The manufactured beverages contain three (3) different quantities of glucose: 50, 75, and 100 grams quantities per 10 oz. bottle. This product is used in the administration of an in Vitro Diagnostic Glucose Tolerance Test in the evaluation of diabetes mellitus and other related disease conditions. This product is for oral consumption only.

{1}

3. Special conditions for use statement(s):
For prescription use only

4. Special instrument requirements:
None

I. Device Description:
The EasyDeX glucose tolerance beverage is a water-based flavored beverage containing specific quantities of dextrose (d-glucose). The product is manufactured in 2 flavors (fruit punch and orange) and 3 concentrations per flavor (50, 75, 100 grams).

J. Substantial Equivalence Information:
1. Predicate device name(s):
Glucose Tolerance Beverage
2. Predicate K number(s):
k032753

2

{2}

3. Comparison with predicate:

|   | Candidate Device Vineland Syrup EasyDeX Glucose Tolerance Beverage | Predicate Device PERK Scientific Glucose Tolerance Beverage (k032753)  |
| --- | --- | --- |
|  Intended use | Same | The Glucose Tolerance Beverage is intended to be used as an accessory to an oral glucose tolerance test in the evaluation of diabetes mellitus and related disease conditions.  |
|  Sugar Composition | Same | Dextrose  |
|  Concentrations | Same | 50, 75, 100 grams  |
|  Bottle | Same | Plastic  |
|  Cap | Same | Tamper Evident Band  |
|  Flavors | Same | Orange, Fruit Punch  |
|  Carbonation | Same | No  |
|  Shelf Life | Same | 18 months  |
|  Bottle Size | Same | 10 ounces  |
|  Lot Number/Expiration Date | Printed on Container | Printed on Bottle Neck  |

K. Standard/Guidance Document Referenced (if applicable):
None

L. Test Principle:
This product is used in the administration of the oral glucose tolerance test. Patients are instructed not to eat or drink anything after midnight before the test. After the glucose load is consumed, blood samples are drawn for glucose measurements at specific time intervals to determine potential defects in insulin secretion and/or insulin action. Fifty gram glucose loads are typically administered for the initial screening of gestational diabetes. Seventy-five gram glucose loads are typically administered for the diagnosis of diabetes mellitus. One hundred gram glucose loads are typically administered for the diagnosis of gestational diabetes.

M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
Not Applicable

{3}

b. Linearity/assay reportable range:
Not applicable

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Traceability:
Not applicable

Stability:
As part of the shelf life evaluation studies, stability studies included sugar composition and microbiological (yeast and molds) testing at various intervals on all 6 products (flavors/concentrations).

Stability study protocols and acceptance criteria were reviewed and found acceptable. Real time stability studies are ongoing.

Expected Values:
Not applicable

d. Detection limit:
Not applicable

e. Analytical specificity:
Not applicable

f. Assay cut-off:
Not applicable

2. Comparison studies:
a. Method comparison with predicate device:
Not applicable
b. Matrix comparison:
Not applicable

3. Clinical studies:
a. Clinical Sensitivity:
Not applicable
b. Clinical specificity:
Not applicable
c. Other clinical supportive data (when a. and b. are not applicable):
Not applicable

{4}

4. Clinical cut-off:
Not applicable

5. Expected values/Reference range:
Not applicable

N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

O. Conclusion:
The submitted information in this premarket notification is complete and supports a substantial equivalence decision.

5

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/MRV/K120247](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/MRV/K120247)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com